Ascentage Pharma Group International (NASDAQ:AAPG) Trading Up 3.5% – Here’s What Happened

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) shares were up 3.5% on Wednesday . The company traded as high as $40.23 and last traded at $40.23. Approximately 6,795 shares traded hands during mid-day trading, a decline of 18% from the average daily volume of 8,278 shares. The stock had previously closed at $38.88.

Ascentage Pharma Group International Stock Performance

The business’s 50 day moving average price is $40.85 and its two-hundred day moving average price is $33.02. The company has a quick ratio of 1.53, a current ratio of 1.54 and a debt-to-equity ratio of 1.31.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in AAPG. Monashee Investment Management LLC bought a new position in Ascentage Pharma Group International in the 1st quarter valued at approximately $3,511,000. Tema Etfs LLC bought a new position in Ascentage Pharma Group International in the 2nd quarter valued at approximately $610,000. Hsbc Holdings PLC bought a new position in Ascentage Pharma Group International in the 2nd quarter valued at approximately $391,000. Finally, Chevy Chase Trust Holdings LLC bought a new position in Ascentage Pharma Group International in the 2nd quarter valued at approximately $227,000.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.